Sofdra Gel
Product Images NDC 83723-010

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Sofdra (NDC 83723-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Botanix Sb Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sofdra 01)

Chemical structure of sofpironium bromide, the active ingredient in Sofdra topical gel. The diagram shows the molecular arrangement, including bromide ion and multiple chiral centers indicated by stereochemical notation.*

FDA Label Image

Image (Sofdra 02)

FDA Label Image

Figure A (Sofdra 03)

An instructional diagram showing components of Sofdra gel packaging. It illustrates the assembly from a blue cap, gel applicator with an applicator top, to the pump bottle labeled Sofdra (sofpironium bromide) 87 mg/.67 mL. Each part is clearly labeled to demonstrate its position on the final product container.*

FDA Label Image

Figure B (Sofdra 04)

An instructional figure showing a clock face with the time set close to midnight, labeled "Bedtime," next to a stylized crescent moon. It likely indicates the recommended application time for the product.*

FDA Label Image

Image (Sofdra 05)

Sofdra gel 87 mg/.67 mL topical medication packaging label by Botanix SB Inc. The label features product and manufacturer information, including the brand name, active ingredient sofpironium bromide, strength, dosage form, and NDC code 83723-010.*

FDA Label Image

Image (Sofdra 06)

Sofdra gel packaging label showing the product name Sofdra, active ingredient sofpironium bromide, with a strength of 87 mg per 0.67 mL. The label identifies the dosage form as a topical gel and lists Botanix SB Inc. as the labeler. The NDC number 83723-010 is present on the package.*

FDA Label Image

Image (Sofdra 07)

The image shows a primary tube packaging of Sofdra gel containing the active ingredient sofpironium bromide at a strength of 87 mg per 0.67 mL. The gel is for topical use and the labeler is Botanix SB Inc. The packaging is white with green and blue text and includes dosage and application instructions.*

FDA Label Image

Image (Sofdra 08)

Sofdra 87 mg/.67 mL gel by Botanix SB Inc. is shown in a white and green box packaging. The label includes the proprietary name Sofdra, the generic name sofpironium bromide, and indicates it is a topical gel prescription drug. The box design features green and gray accents with dosage and product information clearly visible.*

FDA Label Image

Figure C (Sofdra 09)

The image shows the Sofdra 87 mg/.67mL topical gel container by Botanix SB Inc. The container is white with a blue cap and has a white label featuring the Sofdra brand name and the nonproprietary name sofpironium bromide. The container is designed for human prescription drug use.*

FDA Label Image

Figure D (Sofdra 10)

Illustration of a human hand holding a small piece of cloth or tissue. The image is labeled as Figure D and likely demonstrates a step involving wiping or cleaning.*

FDA Label Image

Figure E (Sofdra 11)

Illustration reminding users to check the expiration date on the product. The image shows an eye looking towards a topical gel container with a magnified view highlighting the area where the expiration date (formatted as YYYY-MM-DD) is printed on the container labeled as Figure E.*

FDA Label Image

Figure F (Sofdra 12)

An instructional illustration showing a hand removing a blue cap from the top of a container or device. The image includes a black upward arrow indicating the cap should be pulled off, with the text 'Pull off Blue Cap' displayed beside it.*

FDA Label Image

Figure G (Sofdra 13)

An instructional illustration shows a hand pulling off a gel applicator cap from a Sofdra topical gel bottle labeled with blue text. The image includes an upward arrow and text reading "Pull off Gel Applicator" indicating how to remove the applicator from the bottle.*

FDA Label Image

Image (Sofdra 14)

An instructional flowchart asking, 'Are you using a new SOFDRA Bottle?' with directional arrows guiding to step 5 if 'Yes' and to skip step 5 and go to step 6 if 'No.' The chart uses black text on a yellow and white background.*

FDA Label Image

Figure H (Sofdra 15)

An instructional diagram showing a hand dispensing gel from a pump bottle labeled Sofdra into a sink. The text instructs to "Prime pump into sink," indicating preparation for initial use.*

FDA Label Image

Figure I (Sofdra 16)

Illustration showing a rinse sink with running water flowing from the faucet into the basin, labeled as Figure 1. This diagram appears to instruct rinsing at a sink.*

FDA Label Image

Figure J (Sofdra 17)

An instructional diagram depicting a person exposing both underarms, with emphasis on the underarm area highlighted in blue. The text "Expose both underarms" is displayed next to the image, indicating a step for topical application preparation or treatment.*

FDA Label Image

Figure K (Sofdra 18)

An instructional illustration showing a person drying both underarms with a cloth or towel. The image emphasizes the step of drying underarms, presumably as part of a topical drug application process.*

FDA Label Image

Figure L (Sofdra 19)

An instructional illustration showing a person dispensing one pump of Sofdra gel onto the top of an applicator. The label on the dispensing container reads Sofdra. The image emphasizes applying only one pump of gel to the applicator tip for topical use.*

FDA Label Image

Figure M (Sofdra 20)

An instructional illustration showing a person applying gel to their first underarm. Blue arrows indicate spreading the gel on the skin, demonstrating proper topical application technique for Sofdra gel.*

FDA Label Image

Figure N (Sofdra 21)

An instructional illustration showing application of Sofdra gel, topical sofpironium bromide. It depicts one hand pressing the pump of the gel bottle to dispense a single pump of gel onto the top of an applicator held by the other hand. Text instructs to put only one pump of gel on top of the applicator.*

FDA Label Image

Figure O (Sofdra 22)

An instructional illustration showing a person applying gel to the second underarm using a container. Blue arrows indicate the motion for applying the gel. The image includes the text 'Apply to second underarm.'*

FDA Label Image

Figure P (Sofdra 23)

Illustration labeled Figure P showing a stylized clock face with the instruction "Wait at least 5 Minutes" prominently displayed in the center, indicating a recommended waiting period of five minutes.*

FDA Label Image

Figure Q (Sofdra 24)

An instructional illustration labeled Figure Q shows a hand holding a small container under running water from a faucet, positioned over a sink, indicating rinsing or cleaning of the container.*

FDA Label Image

Figure R (Sofdra 25)

An instructional illustration depicting a hand wiping the top and threads of a small cylindrical container or bottle with a cloth or tissue, emphasizing proper cleaning before opening. Labeled as Figure R, it likely accompanies instructions for using the topical gel Sofdra (sofpironium bromide) 87 mg/.67 mL from Botanix SB Inc.*

FDA Label Image

Figure S (Sofdra 26)

An instructional illustration showing hands being washed under a running faucet with water and soap bubbles visible. The image highlights the handwashing process, likely as a hygiene demonstration associated with topical product use.*

FDA Label Image

Figure T (Sofdra 27)

An instructional illustration showing two hands operating a cylindrical container with a pump dispenser. One hand presses the pump top downward, while the other stabilizes the base, demonstrating proper use of a topical gel container, likely for Sofdra gel 87 mg/.67mL.*

FDA Label Image

Figure U (Sofdra 28)

Illustration demonstrating the application technique for a topical gel product. It shows a person's hand holding a container while the other hand presses down on the pump dispenser with a downward arrow indicating the direction to push for dispensing the gel.*

FDA Label Image

Figure W (Sofdra 29)

Illustration showing a clock face with the instruction to wait at least 8 hours, indicating a recommended time interval likely related to the use or application of the medication Sofdra (sofpironium bromide) topical gel.*

FDA Label Image

Figure X (Sofdra 30)

An instructional illustration showing a blue-capped bottle of Sofdra (sofpironium bromide) topical gel positioned next to an open cabinet with empty shelves, indicating placement or storage inside the cabinet. The gel bottle is white with a blue cap and a label, depicted next to a brown cabinet with two shelves visible.*

FDA Label Image

Figure Y (Sofdra 31)

An instructional diagram labeled "Figure Y" showing a calendar page with the number 30 and the text "Daily Dose," illustrating a 30-day daily dosage schedule.*

FDA Label Image

Principal Display Panel (50 mL Bottle Carton)

Packaging label for Sofdra (sofpironium bromide) topical gel, 12.45%, in a 50 mL multi-dose metered pump bottle. Label includes usage instructions, warnings about flammability, and storage conditions. Manufactured by Botanix SB Inc., Wayne, PA. The label also features a diagram of the gel applicator components and emphasizes the need to read instructions for use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.